HUMAN PAPILLOMA VIRUS (HPV)
Clinical trials for HUMAN PAPILLOMA VIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could zap away common warts
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older will apply the gel to their warts to see if it clears them completely by day 84. The goal is to find a safe and effective treatment for warts on the body.
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier trials for common warts. They can receive up to 4 more treatments with YCANTH, a liquid applied to each wart every 21 days. The goal is to see if the treatment is safe and can clear all warts over about a year. Around 600…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Massive health survey aims to uncover hidden disease hotspots in cambodia
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies to over 50 different infectious diseases, including dengue, flu, and malaria. The goal is to map where and how these diseases spread in communities, involving people aged 2 to 75 who have lived in a village for at leas…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Blood test may predict cervical cancer treatment success
Knowledge-focused Recruiting nowThis study is testing two new blood tests that look for HPV DNA and RNA to see how well cervical cancer responds to standard treatments like surgery, radiation, and chemotherapy. About 55 adults with HPV-related cervical cancer will give blood samples before and after treatment. …
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC